HIGHLIGHTS
- who: Hung Shen and collaborators from the Department of Obstetrics and Gynecology, National Taiwan University Hospital, Hsin-Chu Branch have published the Article: Protein Glycosylation as Biomarkers in Gynecologic Cancers, in the Journal: Diagnostics 2022, 3177 of 15/Dec/2022
- future: CA15-3 could be a biomarker for ovarian and endometrial cancer especially for tumor progression or metastasis but more studies are needed to determine its fitness for clinical use.
SUMMARY
Ovarian cancer has the highest mortality rate among gynecologic cancers, with a 5-year survival rate of 27% for stage . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.